Company Email Format Management

Lexeo Therapeutics

Biotechnology Research 345 Park Avenue South 82 employees

Employees: 82
Contacts: 3
Emails: 3
Phones: 1

lexeotx.com LinkedIn Crunchbase

Lexeo Therapeutics Overview

Headquarters: 345 Park Avenue South
Phone Number: Available in AeroLeads
Website: lexeotx.com
Industry: Biotechnology Research
Employees: 82
Founded: 2018
Funding: 80.0M
Company Email: Available in AeroLeads
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

About Lexeo Therapeutics

Based in New York City, Lexeo Therapeutics is a clinical-stage genetic medicines company dedicated to transforming healthcare by applying pioneering science to fundamentally change how disease is treated. Building on groundbreaking research from Weill Cornell Medicine and the University of California San Diego, Lexeo partners with preeminent institutions on the cutting edge of gene therapy research. Using a stepwise development approach, Lexeo is leveraging early proof-of-concept functional and biomarker data to advance a pipeline of cardiovascular and APOE4 associated Alzheimer's disease programs, and is led by pioneers and experts with decades of collective experience in genetic medicines, rare disease drug development, manufacturing and commercialization. For more information, please visit www.lexeotx.com.

Lexeo Therapeutics Contact Details

People in AeroLeads: 4
With contact data: 3
Email contacts: 3; 75.0% coverage
Phone contacts: 1; 25.0% coverage

Lexeo Therapeutics Org Chart

Sample employees and titles

Name	Title	Location	Contact
Vincent Turula		New York, United States	Email
Sandip Agarwala	Managing Director at Blue Owl Capital	New York City Metropolitan Area, United States	Email Phone
Tolga Tanguler	Executive Vice President, Chief		View
Joslyn Arnon Crowe	Patient Engagement & Advocacy	Weston, Connecticut, United States	Email